In conclusion, the immunohistochemical expression of macroH2A1 was more highly expressed in breast cancer with presence of metastases, finding that macroH2A1 is more highly expressed in breast cancer with poorer prognosis. This evidence concerns the gene MACROH2A1 and breast carcinoma.